Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure

By sjmartinez • April 8, 2025

Anderson E, Choi Y, Buchsbaum RJ, Klein A, Ky B, Landsburg D, Durani U, Ruddy KJ, Yu AF, Leong D, Asnani A, Neilan TG, Ganatra S, Bloom M, Barac A, Yang EH, Deswal A, Cheng RK, Weiss M, Evens AM, Kahl B, Friedberg JW, Parsons SK, Upshaw JN. Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure. Leuk Lymphoma. 2025 Apr 8:1-10. doi: 10.1080/10428194.2025.2484367. Epub ahead of print. PMID: 40195874.

Tags: anthracycline, Cancer, Cancer survivorship, Cardiology/Epi, cardiomyopathy, cardioprotection, heart failure, Publications

Association of BMI and Cognitive Performance in the Diabetes Prevention Program Outcomes Study

Luchsinger JA, Pan Q, Knowler WC, Munshi M, Watson K, Gadde KM, Schlögl M, Carmichael OT; DPP Research Group. Association of BMI and Cognitive Performance[...]

A Case of Premature Ventricular Contraction-Induced Cardiomyopathy

Mazar M, Hingorany S. A Case of Premature Ventricular Contraction-Induced Cardiomyopathy. Cureus. 2025 Aug 26;17(8):e91034. doi: 10.7759/cureus.91034. PMID: 41018405; PMCID: PMC12462810.

Efficacy and safety of colchicine in patients with coronary artery disease: An updated meta-analysis of randomized controlled trials

Ahmed M, Hashmi TM, Shafiq A, Ashraf H, Jain H, Khanji MY, Providência R, Chahal AA, Rana JS, Farhan M, Ahmed R, Fudim M, Fonarow[...]